It has been demonstrated that unconcealed allocation is the most important source of bias in randomized trials7 (link) and, as such, we included only those trials where allocation concealment was determined unambiguously to be adequate (further detail in the review protocol6 (link)). Where necessary, we contacted authors for further information concerning the exact logistics of the randomization process. Trials were excluded if there was any ambiguity about allocation concealment.
Chronic Headache
It encompasses a wide range of primary and secondary headache disorders, such as migraine, tension-type headache, and medication-overuse headache.
These conditions are characterized by throbbing, stabbing, or dull pain in the head, neck, or face, often accompanied by other symptoms like nausea, vomiting, and sensitivity to light or sound.
Effective management of Chronic Headache involves a multidisciplinary approach, including pharmacological and non-pharmacological treatments, as well as lifestyle modifications.
Reserach in this area aims to improve understanding of the underlying pathophysiology, identify novel therapeutic targets, and develop more effective interventions to alleviate the burden of this debilitating condition.
Experiance the power of PubCompare.ai today to optimize your Chronic Headache reserach and take your work to the next level.
Most cited protocols related to «Chronic Headache»
All patients were tested twice with a time interval of 48 to 60 h between completed questionnaires. We assumed that 48 h was enough time for patients not to recall the results of the first completed questionnaire. By that, the 2 time windows of 90 days recall were highly congruent. For reliability testing, the period of 2 days was considered to be equivalent to that of 2 weeks [29 (link)]. The first questionnaire was given to the in-house patients on Friday and patients were asked to fill out the questionnaire on Friday evening after the last medical treatment. The second questionnaire was filled out on Monday morning before the first treatment. The time period in between was considered as stable because no medical treatment was administered.
We identified participants from searches of general practice records from 14 practices in the West Midlands region of the UK that cover urban, small town and semi-rural areas with varying levels of deprivation and ethnic diversity. We searched for people who had consulted within the previous year with headache, or had been prescribed migraine specific medication. Due to the typically imprecise coding of chronic headache in primary care and the fluctuating nature of headache frequency the search included people with both episodic and chronic headaches. GPs screened lists of participants identified from the searches and excluded those with known serious underlying pathology or secondary causes of headache (other than medication overuse headache) or terminal illness because we did not want to cause unnecessary upset or distress inviting them to take part in a study of a self-management intervention for chronic headache. People interested in the study were contacted by a member of the study team to confirm that they had experienced headaches for at least half the days of the month and for at least three months. People who met these criteria and provided written consent were invited to take part in two telephone interviews, the first a telephone classification interview conducted by specially trained nurses and the second a validation interview conducted by doctors working for the National Migraine Centre. The nurse interviews were audio recorded for quality assurance purposes.
Briefly, in each study province, all departments where pigs were raised (30 of 31 departments) were selected, and two villages meeting the eligibility criteria were randomly selected from each department for a total of 60 participating villages. Eligible villages had a population of at least 1 000 people as according to the 2006 census, were on the map provided by the Burkina Faso Geographic Institute (2000), were at least 5 km away from another participating village, were not located on a national or provincial road, were not the capital of the region or of the province, and were not located within 20 km of Koudougou or Ouagadougou. In each of the participating villages, 80 concessions were selected (a grouping of several households, usually members of the same family), including at least ten concessions with sows and at least 30 with pigs aged less than 12 months. One household was selected at random from each concession. In each sampled household, one eligible member was randomly selected to participate in a 3-year follow-up study on epilepsy and chronic headaches. As part of the follow-up study, participants had to answer a baseline questionnaire that was included in the present study (see Additional file
Villages used in the pilot study, GDs, and questionnaire survey during the planning of the health education intervention strategy to control taeniasis and cysticercosis in Burkina Faso, 2007–2012. One village (green star) was involved in both the pilot and the main study
Most recents protocols related to «Chronic Headache»
54. Other chronic headache (including cluster headache, tension headache)
55. Epilepsy
56. Multiple sclerosis
57. Spina bifida
58. Idiopathic intracranial hypertension
59. Peripheral neuropathy
60. Other neurological conditions/musculoskeletal disorders
Primary diagnoses currently handled in DS-RPM
Tension-type headache |
Migraine and its various presentations (e.g., with/without aura) |
Cerebrovascular accident (CVA) and its subcategories |
Intracranial space-occupying lesions of various etiologies (neoplasia, vascular, acute/chronic pituitary disorders) |
Trigeminal autonomic cephalalgias—cluster headache, paroxysmal hemicrania, hemicrania continua, short-lasting unilateral neuralgiform headache with autonomic symptoms/conjunctival tearing (SUNA/SUNCT) |
Neuralgic disorders: trigeminal neuralgia, glossopharyngeal neuralgia, occipital neuralgia, post-herpetic neuralgia |
Systemic causes of headache: e.g., temporal (giant-cell) arteritis, pheochromocytoma, lupus erythematosus |
Disorders of the salivary glands—sialadenitis, sialadenosis, neoplasia, Sjogren–Mikulicz disease |
Temporomandibular joint disorders |
Disorders of the paranasal sinuses |
Infective causes of CNS inflammation—meningitis, encephalitis, HIV, Lyme disease |
Toothache and its differential/root causes: Caries, abscess, trigeminal neuralgia, etc |
Optic neuritis and its root causes (e.g., multiple sclerosis, neuromyelitis optica) |
Ophthalmic causes of headache/facial pain (e.g., uveitis, keratoconjunctivitis, refractive errors) |
Cavernous sinus disorders—thrombosis, Tolosa–Hunt syndrome |
Opioid risk (with the creators’ permission): the 8-item Revised (2019) Opioid Risk Tool for Opioid Use Disorder (ORT-OUD) [41 (link)]. The ORT-OUD Risk Score is used to generate a risk-stratified treatment plan for opioid use where appropriate.
Depression: Chronic pain can cause depression. The 9-item Patient Health Questionnaire (PHQ) is activated if the patient responds to either of two questions in the history (“Little pleasure in doing things”; “Feeling down, depressed, or hopeless”) with “More than half the days” or worse [42 (link)].
Suicide risk: The National Institute of Mental Health’s 4-item ASQ (Ask Suicide Screening Questions) scale is activated after a non-negative response to the PHQ question “Thoughts that you would be better off dead, or of hurting yourself.” Chronic pain is an important risk factor for suicide [43 (link)]: chronic headache posed higher suicide risk than other chronic pain types in a 10-year veterans’ retrospective study [44 (link)].
Patients with chronic tension-type headache who were included in the examination could receive preventive or therapeutic treatment with pain-killing drugs with the doctors’ consent or when they have a headache.
Subjects in the healthy control group were required to be in a healthy state and have no headache within the last year, no medication in 1 month, and no family history of headache. The subjects did not consume alcohol, caffeine, or other substances for at least 3 days before MRI.
According to the power analysis, we needed at least 524 patients in each group to detect a mean concussion incidence difference of 10% between the CH and NH cohorts, at 80% power and with a Type I error set at 0.05.
Chi-squared tests were used to compare categorical variables and concussion incidence. Continuous variables were presented as the mean ± standard deviation if they were normally distributed according to the Kolmogorov-Smirnov test. Means of normally distributed continuous variables were compared using a t-test. If not normally distributed, continuous variables were presented as the median and interquartile range. Medians were compared using the Kruskal-Wallis test. Significant univariate variables were included in a multivariate logistical regression to assess for risk factors of chronic headaches. Pertinent risk factors, specifically a history of concussions, were further analyzed as a function of chronic headache and symptom burden, as reported on the PCSS survey administered at the beginning of the season. Headache burden was rated on an overall scale ranging from 0 to 54 that assessed the intensity of headache, vomiting, nausea, balance, dizziness, sensitivity to light, sensitivity to noise, numbness, and visual changes on independent scales of 0 to 6. Symptom burden included all 22 measures on the baseline PCSS survey. For the analysis, past concussions were stratified by their number and characteristics, including confusion, anterograde amnesia, retrograde amnesia, and loss of consciousness.
Next, a multivariate model accounting for variables shown to modulate chronic headaches was used to compare the incidence of future concussion among those reporting a history chronic headache and those reporting no such history. Future concussion incidence was also analyzed as a function of initial headache burden. Separate multivariable logistic regressions were then conducted to assess for the role of chronic headaches on concussion severity and recovery as measured by deviations from baseline to PI and then to FU in the five composite scores. In the multivariate model assessing concussion recovery loss to FU, latency to FU, and deviations from baseline to PI in the five composite scores were included as confounding variables. Latency to FU was defined as the time elapsed between the PI and FU tests. A final set of multivariable linear regressions were used to assess the role of baseline demographic variables and headache burden on concussion severity and recovery.
A p-value < 0.05 was considered significant for all tests. RStudio 3.6 (R Foundation for Statistical Computing) was used for data analysis and Adobe Illustrator 27.0 (Adobe Incorporated) was used for figure creation.
Top products related to «Chronic Headache»
More about "Chronic Headache"
Chronic headaches are a debilitating condition characterized by recurring, long-lasting head, neck, or facial pain.
These headaches can significantly impact an individual's quality of life and encompass a wide range of primary and secondary headache disorders, such as migraine, tension-type headache, and medication-overuse headahe.
Individuals with chronic headaches often experience throbbing, stabbing, or dull pain, accompanied by other symptoms like nausea, vomiting, and sensitivity to light or sound.
Effective management of chronic headaches requires a multidisciplinary approach, including pharmacological and non-pharmacological treatments, as well as lifestyle modifications.
Reserach in this area aims to improve understanding of the underlying pathophysiology, identify novel therapeutic targets, and develop more effective interventions to alleviate the burden of this debilitating condition.
Tools like SPSS, GraphPad Prism, and EndNote can be leveraged to optimize data analysis and streamline the research process.
Experiance the power of PubCompare.ai today to take your chronic headache reserach to the next level.